| 000 | 01428 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516232749.0 | ||
| 264 | 0 | _c20151030 | |
| 008 | 201510s 0 0 eng d | ||
| 022 | _a1872-8111 | ||
| 024 | 7 |
_a10.1016/j.neures.2014.08.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReinbold, Emily D | |
| 245 | 0 | 0 |
_aCentral CRF2 receptor antagonism reduces anxiety states during amphetamine withdrawal. _h[electronic resource] |
| 260 |
_bNeuroscience research _cDec 2014 |
||
| 300 |
_a37-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmphetamine _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnxiety _xchemically induced |
| 650 | 0 | 4 | _aInfusions, Intraventricular |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Corticotropin-Releasing Hormone _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSubstance Withdrawal Syndrome _xpsychology |
| 650 | 0 | 4 | _aCRF Receptor, Type 1 |
| 700 | 1 | _aScholl, Jamie L | |
| 700 | 1 | _aOliver, Kathryn M | |
| 700 | 1 | _aWatt, Michael J | |
| 700 | 1 | _aForster, Gina L | |
| 773 | 0 |
_tNeuroscience research _gvol. 89 _gp. 37-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neures.2014.08.010 _zAvailable from publisher's website |
| 999 |
_c24175699 _d24175699 |
||